NEXT Financial Holdings’s Charles River Laboratories CRL Stock Holding History

NEXT Financial Holdings’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$280K	Buy	+1,929	New	+$253K	0.07%	278

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

NEXT Financial Holdings's CRL Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Charles River Laboratories (CRL) in Q1 2019: 1,929 shares worth $280K. The stake represents 0.07% of the portfolio and ranks #278 among its holdings.

409 funds tracked by Wall St. Rank hold CRL as of Q1 2019.

NEXT Financial Holdings held 1,929 shares of Charles River Laboratories worth $280K as of Q1 2019.
Charles River Laboratories was a new NEXT Financial Holdings position in Q1 2019.
Charles River Laboratories made up 0.07% of NEXT Financial Holdings's portfolio in Q1 2019, its #278 holding.
409 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.